La Dra. Begoña Benito Villabriga analiza los resultados del estudio publicado en ESC Congress 2019.

1. Begoña Benito VillabrigaDAPA TrialDAPA Trial

2. Begoña Benito VillabrigaDAPA Trial
Background
MADIT II IRIS

3. Begoña Benito VillabrigaDAPA Trial
Background

4. Begoña Benito VillabrigaDAPA Trial
Background

5. Begoña Benito VillabrigaDAPA Trial
Objective

6. Begoña Benito VillabrigaDAPA Trial
Study design
Inclusion criteria:

7. Begoña Benito VillabrigaDAPA Trial
Results

8. Begoña Benito VillabrigaDAPA Trial
Results: patient characteristics

9. Begoña Benito VillabrigaDAPA Trial
Results: ICD implant and study groups
 Cross-over

10. Begoña Benito VillabrigaDAPA Trial
Results: primary end-point

11. Begoña Benito VillabrigaDAPA Trial
Results: secondary end-points

12. Begoña Benito VillabrigaDAPA Trial
Results

13. Begoña Benito VillabrigaDAPA Trial
Limitations
 Premature termination in 2013 (38% of patients), underpowered to
answer the hypotheses: interpretation of results?
 First inclusion in 2004: dramatic improvement in MI and HF
management

14. Begoña Benito VillabrigaDAPA Trial
Conclusions